Under value-based care models, two clinical decisions carry outsized financial consequences in post-surgical orthopedic episodes: where a patient recovers after discharge, and whether a complication develops before the episode closes. Both have historically been made with incomplete information. This white paper shows what becomes possible when that gap closes.

What's inside

Two de-identified patient cases from the OneStep platform illustrate the clinical and financial opportunity created by continuous, objective gait monitoring:

• IRF avoidance: A post-THR patient appeared high-risk at discharge. Longitudinal gait data revealed a clear recovery trajectory — enabling a confident home-based discharge and avoiding an unnecessary inpatient rehab stay worth $8–12K more per episode.
• Fall prevention: An 84-year-old rated her own fall risk as "low." Her gait data signaled elevated risk for weeks before she fell. The signal existed. The intervention didn't — and the readmission cost ran $15–25K.

Together, these cases represent the two primary cost levers in post-acute orthopedic care: unnecessary inpatient rehab utilization and avoidable complications after discharge.